Invizyne Technologies Inc. (NASDAQ:IZTC) CEO Buys $22,022.40 in Stock

Invizyne Technologies Inc. (NASDAQ:IZTC) CEO Michael Heltzen purchased 1,984 shares of Invizyne Technologies stock in a transaction on Friday, November 15th. The shares were acquired at an average price of $11.10 per share, for a total transaction of $22,022.40. Following the completion of the transaction, the chief executive officer now directly owns 1,984 shares of the company’s stock, valued at approximately $22,022.40. The trade was a ∞ increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Invizyne Technologies Stock Up 10.6 %

Shares of IZTC opened at $14.50 on Friday. Invizyne Technologies Inc. has a fifty-two week low of $8.50 and a fifty-two week high of $14.50.

About Invizyne Technologies

Invizyne Technologies Inc is a cell-free enzyme-based biomanufacturing technology company. It redefining biomanufacturing by leveraging cell-free, multi-step, enzyme-based systems to efficiently transform natural or renewable resources into highly sought after biochemicals. Invizyne Technologies Inc is based in Monrovia, CA.